Research Grant-to-Startup Pathway

Define a practical, sequenced plan for Research Grant-to-Startup Pathway. The objective is to remove ambiguity around research grant to startup pathway, give the founder a decision-ready output, and make it clear whether the venture should progress, repeat the task with stronger evidence, escalate to expert support, or move into a linked stage.

Bertie or a programme manager assigns Research Grant-to-Startup Pathway when the venture needs a decision-ready output for this group. Typical triggers include group-gate reviews, evidence gaps identified by the co-pilot or founder request.

research asset; IP or publication status; research team; technology maturity; candidate applications; specific context for research grant to startup pathway.

1. 1Clarify Commercial Objectives and Strategic Decision Horizonsexpand_more

   The founder defines the precise commercial destination and timeframe for transitioning from research grant funding to an independent corporate entity. This involves mapping grant milestones against spinout timelines to establish a firm go or no-go decision date for formal incorporation. The focus is on setting explicit boundaries between ongoing academic discovery and active commercial venture development.

   Objective

   Establishing this baseline explicitly defines the timeframe and strategic boundaries for transitioning research out of the university environment. It provides the parent task with a clear target date for commercial viability, ensuring subsequent planning remains tightly aligned with corporate realities rather than open-ended academic investigation.

   What's expected

   The founder must deliver a documented target commercialisation date alongside a clear decision-horizon matrix. This output must specify key strategic parameters, including desired venture autonomy, institutional equity thresholds, and explicit criteria for choosing between licensing and spinout creation.

   Consultant stress-test · 5 questions

   1. 1.What specific commercial trigger dictates your decision date rather than simply following the grant expiry schedule?
   2. 2.How have you reconciled the university's expected research milestones with the aggressive pace required for commercial launch?
   3. 3.Why have you chosen this particular decision horizon when key intellectual property claims remain pending?
   4. 4.What evidence demonstrates that your academic co-founders are aligned on this target transition timeframe?
   5. 5.How does this timeline accommodate potential delays in institutional Technology Transfer Office (TTO) sign-off?

   Open action arrow_forward
2. 2Map the Non-Dilutive Grant Transition Architectureexpand_more
3. 3Expose Intellectual Property, Institutional, and Regulatory Dependenciesexpand_more
4. 4Construct a Sequenced Execution Roadmap with Designated Ownersexpand_more
5. 5Establish Quantitative Success Metrics and Escalation Triggersexpand_more
6. 6Integrate the Pathway into Venture DNA and Stage Gatesexpand_more

• A data-room asset titled Research Grant-to-Startup Pathway
• A practical plan with owners, sequencing, assumptions, dependencies, risks and next decision points
• It should update the venture DNA with specific evidence or decisions about research grant to startup pathway, create a visible milestone in the founder journey, and generate one or more recommended next tasks

A mentor or evaluator can review the output at the group gate. Programme managers can require an advisor checkpoint before Bertie moves the venture forward.

Draft your output and let Bertie review it